Uniting Patients and Researchers on the Road to Curing Type 1 Diabetes

Partnerships between patients and scientists are critical for identifying and addressing unmet research and treatment needs. This event, in partnership with Lyfebulb, convened patients, advocates, scientists, and caregivers to discuss the future of type 1 diabetes research and treatment. Panelists explored the treatment options currently available and how these different communities can work together to develop treatments that will improve the lives of patients in the near and long term. Dr. Bjarki Johannesson of the NYSCF Research Institute spoke about his team’s use of stem cells to understand the disease in a whole new light and to create cells for therapeutic applications.

Read a summary of the event and watch highlights here.

Type 1 Diabetes Panel

HOST Susan L. Solomon, JD The NYSCF Research Institute
MODERATOR Karin Hehenberger, MD, PhD Lyfebulb CEO and Founder	PANELIST Lauren Bongiorno Diabetic Health Coach	PANELIST Bjarki Johannesson, PhD The NYSCF Senior Research Investigator
PANELIST Aaron Kowalski, PhD JDRF President & CEO	PANELIST Jennifer Ross Be Mixed Co-founder	PANELIST Stuart Weiss, MD NYU School of Medicine, Clinical Assistant Professor

In collaboration with